We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 16 JUNE 2004
A Prescription for Follow-on Biologics?
Lovells
As can be seen from other recent articles, changes have recently been made to the route for marketing authorisation for pharmaceuticals in the European Community. These rules are not restricted to standard chemical pharmaceuticals, and this article will address the new rules relating to marketing authorisations for "follow-on" biological medicinal products.
European UnionAntitrust/Competition Law








